[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 18, Issue 5 (2-2017) ::
2017, 18(5): 343-350 Back to browse issues page
Status of Serum Resistin and C - reactive protein in Medullary Thyroid Carcinoma: A Potential Diagnostic Marker
N Ahmaripour , M Hedayati , GH Riyazi
, hedayati47@yahoo.com
Abstract:   (6402 Views)

Introduction: Resistin and C-reactive protein secreted from adipose tissue, have endocrine, paracrine and autocrin effects on most metabolism and inflammatory processes. Data available shows associations between inflammation, adipokines and cancer. Medullary thyroid cancer constitutes 5 to 10 percent of thyroid cancer. The goal of this study was to assess serum resistin levels and C-reactive protein in patients with medullary thyroid carcinomas. Materials and Methods: In this study, 90 participantswith medullary thyroid cancer (21 males 29±13.91 and 24 females 29.0±14.52 years), and controls (24 males 23.08±11.58 and 21 females 31.52±14.38 years old) were selected. Resistin and C-reactive protein levels were determined in both groups with ELISA methods.  Height and weight of individuals were measured and body mass index was calculated. Results obtained by t-test were analyzed using the Medcalc version 13.5. Results: Between the two groups in terms of age and BMI differences were not statistically significant. The geometric mean of logarithm transformed differed significantly resistin in the patient group and control groups (1.44 and 2.36 respectively) (P=0.009). Mean C-reactive protein between the control and patient groups was not significantly different (p>0.05). Conclusion: It seams that significant differences in serum levels of Resistin in MTC and control group can be used as an indicator to help confirm the diagnosis of medullary thyroid carcinomas.

Keywords: Resistin, C-reactive protein, Medullary thyroid cancer, Body mass index
Full-Text [PDF 350 kb]   (1878 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2015/05/22 | Accepted: 2016/11/8 | Published: 2017/01/28
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ahmaripour N, Hedayati M, Riyazi G. Status of Serum Resistin and C - reactive protein in Medullary Thyroid Carcinoma: A Potential Diagnostic Marker. Iranian Journal of Endocrinology and Metabolism 2017; 18 (5) :343-350
URL: http://ijem.sbmu.ac.ir/article-1-1942-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 5 (2-2017) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4652